Ozempic and Mounjaro are reshaping South Africa’s health market

The landscape of weight management and diabetes treatment in South Africa is undergoing a dramatic transformation. This change is driven by the meteoric rise in popularity of a class of drugs known as GLP-1s, including Ozempic and Mounjaro. These medications, initially developed for Type 2 diabetes, have shown significant efficacy in promoting weight loss. As a result, there is unprecedented…

Continue reading with a Health Matters subscription

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in